Delivery Order SPE2DB22D3009-SPE2DB24FAP52

Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $9.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract, valued at $16,219.06, has an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a $1,636.97 firm fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of VIVITROL 380 MG VIAL-DILUENTS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $5,817.72 and a period of performance through April 3, 2024. This delivery order is placed under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 380 mg VIVITROL vials and diluents. The $2,798.10 contract has a completion date of February 1, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is not associated with any set-aside program. This award is part of a larger...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The $5,485.92 contract has a completion date of July 29, 2024 and is not set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of essential pharmaceutical and medical supplies to...
The Department of Defense's Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a potential value of $4,509.77 and a completion date of February 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $5,589.11 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565057997 Vivitrol 380 mg vials and diluents. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $6,032.25, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a specialty pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, which has a...
This is a $8,720.45 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The delivery order, valued at $10,971.72, is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialty pharmaceutical product. The delivery order was issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31,...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FAP52
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,588,333 units of VIVITROL 380 MG VIAL-DILUENTS. The order, valued at $9,419.18, has a completion date of February 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Additionally, AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 5/8/24, 10:22 AM